Description: In a clinical study of postmenopausal women with low estrogen levels, Ostera™—in conjunction with a modified Mediterranean, low glycemic diet and regular exercise—was shown to beneficially influence key markers of bone remodeling more than diet and exercise alone. Bone remodeling is the natural process of healthy breakdown and formation of the bone matrix—the structure where minerals are deposited. This scientifically advanced formula features selective kinase response modulators (SKRMs) in the form of RIAA, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process. Recommended for use with Cal Apatite®—an advanced bioactive formulation for bone mineralization.* Promotes healthy bone remodeling biomarkers to support bone quality and integrity.* Clinically shown in a study of postmenopausal women with low estrogen levels to:* Beneficially influence key markers of bone remodeling. Positively influence osteocalcin, a key marker of bone remodeling rate. Offer more effectiveness than diet and exercise alone. Features selective kinase response modulators (SKRMs) in the form of RIAA from hops, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process.* No reported serious adverse effects.
Dosage: Take one tablet twice daily, or as directed by your healthcare practitioner.
Contraindications: Do not use if pregnant or nursing or if taking cyclo-sporine or anticoagulant medication.
Ingredients: Microcrystalline cellulose, stearic acid (vegetable), croscarmellose sodium, calcium silicate, silica, and coating (water, hypromelose, medium chain triglycerides , and hydroxyproylcellulose).